Oncolytics Biotech announced that it is undertaking an overnight marketed offering of units, each comprised of one common share and a portion of a common share purchase warrant. Oppenheimer & Co. Inc. is acting as the sole bookrunning manager for the offering. :theflyonthewall.com
News For ONCY From The Last 14 Days
Check below for free stories on ONCY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
